A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation report
- 1 July 1996
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 74 (2) , 318-322
- https://doi.org/10.1038/bjc.1996.360
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- The importance of dose intensity in the outcome of chemotherapy.1988
- The chemotherapy of lymphomas: looking back, moving forward--the Richard and Hinda Rosenthal Foundation award lecture.1987
- MACOP-B Chemotherapy for the Treatment of Diffuse Large-Cell LymphomaAnnals of Internal Medicine, 1985
- Diffuse Aggressive Lymphomas: Increased Survival After Alternating Flexible Sequences of ProMACE and MOPP ChemotherapyAnnals of Internal Medicine, 1983
- RATIONALE FOR THE USE OF ALTERNATING NON-CROSS-RESISTANT CHEMOTHERAPY1982
- EVALUATION OF VP-16-213 IN MALIGNANT-LYMPHOMA AND MELANOMA1978
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphomaCancer, 1976
- Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomasCancer, 1974